Novavax, Inc. (NVAX) Posts Narrower than Expected Q4 Loss
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.00 --0%
Revenue Growth %: -78.2%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -78.2%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q4 loss of $0.06, 3 cents better than the analyst estimate of ($0.09). Revenue for the quarter came in at $51 thousand versus the consensus estimate of $110 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- Crown Crafts (CRWS) Reports Q4 EPS of $0.03
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
